GUIDELINES ON VALIDATION APPENDIX 5 VALIDATION OF ...
Working document QAS/16.667 page 3 90 Background information 91 92 The need for revision of the published Supplementary guidelines on good manufacturing 93 practices: validation (World Health Organization (WHO) Technical Report Series, No. 937, 94 2006, Annex 4) (1) was identified by the Prequalification of Medicines Programme and a draft 95 document was …
Download GUIDELINES ON VALIDATION APPENDIX 5 VALIDATION OF ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
CODEX GENERAL STANDARD FOR CONTAMINANTS AND …
www.fao.orgThe principles of Good Manufacturing Practice and Good Agricultural Practice as defined by Codex shall be used. ... 2 For the contaminants methylmercury, radionuclides, acrylonitrile and vinylchloride monomer a Codex guideline level (GL) has been established. A Codex guideline level ...
Quality Agreement for Laboratories Guideline Templates
apic.cefic.orgAPIC’s focus is on worldwide Quality, Good Manufacturing Practice (GMP) and Regulatory matters relating to APIs and intermediates. Through the years APIC has developed into a high-profile industry association with an excellent, worldwide reputation. APIC has already developed a series of guidance documents and position papers (see
Q7 Implementation Working Group ICH Q7 Guideline: Good ...
database.ich.orgICH Q7 Guideline: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Questions and Answers Current version dated 10 June 2015. Dated : 10 June 2015 Q7 Q&As i In order to facilitate the implementation of the Q7 Guidelines, the ICH Experts have developed a series of Q&As:
SUPPLIER QUALIFICATION & MANAGEMENT GUIDELINE
www.apic.cefic.orgmanufacturing practice regulations that are designed to ensure their quality, safety and efficacy. This ensures that patients worldwide and at any time can have confidence in the quality, safety and efficacy of medicines. The cGMP regulations for final medicinal products are clearly defined in each country and region.
Guideline Sponsors Responsibilities IMP handling and ...
www.ema.europa.euGuideline on the responsibilities of the sponsor with regard to handling and shipping of investigational medicinal products for human use in accordance with Good Clinical Practice and Good Manufacturing Practice EMA/202679/2018 Page 4/6 . 21 . Introduction
Q 7 Good Manufacturing Practice for Active Pharmaceutical ...
www.ema.europa.euThis document (Guide) is intended to provide guidance regarding good manufacturing practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing quality. It is also intended to help ensure that APIs meet the requirements